REGULATORY
Details of Approvals to Be Provided to Prefectures Prior to Unannounced Inspections: MHLW Official
A health ministry official revealed on January 19 that prefectures that conduct unannounced inspections at pharmaceutical manufacturing facilities have asked the ministry to provide in advance the details of approvals for the products concerned. Prefectures decide which products to inspect,…
To read the full story
REGULATORY
- Japan Targets Global-Level Growth for Domestic Patented Drug Market
June 25, 2026
- Paxlovid, Awiqli Braced for NHI Price Cuts after CEAs
June 25, 2026
- Drug Pricing to Be Applied to Oncolys Oncolytic Virus Therapy
June 25, 2026
- Japan Diet Begins Deliberations on Immunization Act Revision
June 25, 2026
- Expert Calls for AMR Ecosystem to Boost Japan Antibiotic Innovation
June 25, 2026
Recent trends are creating a fascinating push-and-pull effect in the talent market. We’re seeing more positions opening up, but also a greater number of candidates available, particularly in the fields of rare diseases and oncology. This “more positions, more candidates”…





